RecruitingNCT07136467
A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
Multi-Country, Cross-sectional Study to Characterize Real World Burden of Disease in Adolescent and Adult Patients With Alopecia Areata, Vitiligo or Hidradenitis Suppurativa (MEASURE AAVitHS)
Sponsor
AbbVie
Enrollment
2,795 participants
Start Date
Sep 2, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This study is to assess the burden of disease in adolescent and adult participants with moderate or severe alopecia areata (AA), non-segmental vitiligo (NSV), or moderate to severe hidradenitis suppurativa (HS) in a large global real-world participant population.
Eligibility
Min Age: 12 Years
Inclusion Criteria2
- Participants with Physician-confirmed diagnosis of non-segmental vitiligo (NSV), moderate to severe Alopecia Areata (AA), or moderate to severe hidradenitis suppurativa (HS)
- Participants Ability to understand study questionnaires, with caregiver support as required for adolescents
Exclusion Criteria2
- Participating in interventional clinical trial(s) at time of study visit (participation in another non-interventional study or registry does not exclude a participant from this study)
- Unable or unwilling to comply with study requirements and PRO collection
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(116)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07136467
Related Trials
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
NCT0688819311 locations
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
NCT0722556920 locations
A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa
NCT0692185018 locations
Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
NCT059949761 location
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
NCT0704957523 locations